Skip to main content
Log in

Co-Culturing of Multipotent Mesenchymal Stromal Cells with Autological and Allogenic Lymphocytes

  • IMMUNOLOGY AND MICROBIOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the effect of autologous and allogeneic lymphocytes on multipotent mesenchymal stromal cells in co-culture. It is shown that changes in multipotent mesenchymal stromal cells and in lymphocytes did not depend on the source of lymphocytes. Contact with lymphocytes triggers expression of HLA-DR molecules on multipotent mesenchymal stromal cells and these cells lose their immune privilege. In multipotent mesenchymal stromal cells, the relative level of expression of factors involved in immunomodulation (IDO1, PTGES, and IL-6) and expression of adhesion molecule ICAM1 increased, while expression of genes involved in the differentiation of multipotent mesenchymal stromal cells remained unchanged. Priming of multipotent mesenchymal stromal cells with IFN did not affect these changes. In turn, lymphocytes underwent activation, expression of HLA-DR increased, subpopulation composition of lymphocytes changed towards the increase in the content of naïve T cells. These findings are important for cell therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Petinati NA, Kapranov NM, Bigil’deev AE, Popova MD, Davydova YO, Gal’tseva IV, Drize NI, Kuz’mina LA, Parovichnikova EN, Savchenko VG. Changing the Properties of Multipotent Mesenchymal Stromal Cells by IFNγ Administration. Bull. Exp. Biol. Med. 2017;163(2):230-234.

    Article  CAS  PubMed  Google Scholar 

  2. Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat. Biotechnol. 2014;32(3):252-260.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002;30(1):42-48.

    Article  PubMed  Google Scholar 

  4. Bonfield TL, Nolan Koloze MT, Lennon DP, Caplan AI. Defining human mesenchymal stem cell efficacy in vivo. J. Inflamm. (Lond). 2010;7:51. doi: https://doi.org/10.1186/1476-9255-7-51.

    Article  Google Scholar 

  5. Caplan AI, Sorrell JM. The MSC curtain that stops the immune system. Immunol. Lett. 2015;168(2):136-139.

    Article  CAS  PubMed  Google Scholar 

  6. Jones BJ, McTaggart SJ. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp. Hematol. 2008;36(6):733-741.

    Article  CAS  PubMed  Google Scholar 

  7. Kim N, Im KI, Lim JY, Jeon EJ, Nam YS, Kim EJ, Cho SG. Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. Ann. Hematol. 2013;92(10):1295-1308.

    Article  CAS  PubMed  Google Scholar 

  8. Kuzmina LA, Petinati NA, Parovichnikova EN, Lubimova LS, Gribanova EO, Gaponova TV, Shipounova IN, Zhironkina OA, Bigildeev AE, Svinareva DA, Drize NJ, Savchenko VG. Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host Disease-a phase II study. Stem Cells Int. 2012;2012:968213. doi: https://doi.org/10.1155/2012/968213.

    Article  PubMed  Google Scholar 

  9. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 2003;57(1):11-20.

    Article  PubMed  Google Scholar 

  10. Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E. The who’s who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 2013;43(11):2797-2809.

    Article  CAS  PubMed  Google Scholar 

  11. Ringden O, Le Blanc K. Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages. Best Pract. Res. Clin. Haematol. 2011;24(1):65-72.

    Article  CAS  PubMed  Google Scholar 

  12. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008;3(6):1101-1108.

    Article  CAS  PubMed  Google Scholar 

  13. Tyndall A, Houssiau FA. Mesenchymal stem cells in the treatment of autoimmune diseases. Ann. Rheum. Dis. 2010; 69(8):1413-1414.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. I. Drize.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 10, pp. 442-448, October, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kapranov, N.M., Davydova, Y.O., Gal’tseva, I.V. et al. Co-Culturing of Multipotent Mesenchymal Stromal Cells with Autological and Allogenic Lymphocytes. Bull Exp Biol Med 164, 446–452 (2018). https://doi.org/10.1007/s10517-018-4009-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4009-x

Key Words

Navigation